TransMedics Group, Inc. TMDX

TMDX Company Overview

TransMedics Group, Inc. is a U.S.-based medical technology company focused on organ transplant therapy and organ preservation systems. The company operates within the healthcare technology and medical devices industries, specializing in solutions designed to improve organ utilization, preservation, and transportation for heart, lung, and liver transplantation. Its primary revenue driver is the Organ Care System (OCS) platform, a portable normothermic machine perfusion system that enables donor organs to remain functioning outside the body during assessment and transport. The company also generates revenue from disposable products used with the OCS platform and from organ logistics and transplant support services.

TransMedics has positioned itself as a differentiated provider in transplant medicine through its integrated “organ procurement-to-transplant” model. The company’s strategy combines proprietary organ perfusion technology with logistics and clinical support services intended to increase transplant volume and improve clinical outcomes. Founded in 1998, TransMedics evolved from a medical device innovator focused on organ preservation into a broader transplant services company, particularly after expanding into aviation and logistics capabilities to support nationwide organ transportation and procurement operations.